603102 Weihai Baihe Biology Technological
- 31.12
- -0.34-1.08%
Weihai Baihe Biology Technological News
Announcement of Weihai Baihe Biotechnology Co., Ltd. on holding the 2023 Annual Results Briefing
Weihai Baihe Biotechnology Co., Ltd. 2023 Annual Equity Distribution Implementation Notice
Guangfa Securities Co., Ltd.'s inspection opinion on the differentiated distribution of rights of Weihai Baihe Biotechnology Co., Ltd.
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Weihai Baihe Biotechnology Co., Ltd.
Legal Opinions of Beijing Junzejun Law Firm on the 2023 Annual General Meeting of Shareholders of Weihai Baihe Biotechnology Co., Ltd.
Lily Co., Ltd. Investor Relations Activity Record List for April 2024
Announcement of Weihai Baihe Biotechnology Co., Ltd. on revising the “Articles of Association” and part of the company's governance system
Articles of Association of Weihai Baihe Biotechnology Co., Ltd. (revised in April 2024)
Working rules for independent directors of Weihai Baihe Biotechnology Co., Ltd. (revised in April 2024)
Announcement of Resolutions of the 7th Meeting of the Fourth Board of Directors of Weihai Baihe Biotechnology Co., Ltd.
Announcement of Weihai Baihe Biotechnology Co., Ltd. on the 2023 Profit Distribution Plan
Announcement of Resolutions of the 6th Meeting of the Fourth Board of Supervisors of Weihai Baihe Biotechnology Co., Ltd.
Weihai Baihe Biotechnology Co., Ltd. special report on the storage and actual use of funds raised by the company in 2023
Special inspection report of GF Securities Co., Ltd. on the storage and use of funds raised by Weihai Baihe Biotechnology Co., Ltd. in 2023
Weihai Baihe Biotechnology Co., Ltd. raised capital annual storage and use verification report
Announcement of Weihai Baihe Biotechnology Co., Ltd. on the use of some temporarily idle funds raised and own funds for cash management
Opinions of Guangfa Securities Co., Ltd. on the verification of Weihai Baihe Biotechnology Co., Ltd.'s use of some temporarily idle funds raised and own funds for cash management
Weihai Baihe Biotechnology Co., Ltd. announced the main operating data for the first quarter of 2024
Announcement of Weihai Baihe Biotechnology Co., Ltd. on renewing the employment of an accounting firm
Weihai Baihe Biotechnology Co., Ltd. 2023 Independent Director Debriefing Report (Zhou Xiaoli)
Analysis
Price Target
No Data
